In the training set, the risk signature could not stratify the prognosis of three subgroups (TMZ non-treated MGMT unmethylated GBM, TMZ treated MGMT methylated GBM, and TMZ non-treated MGMT methylated GBM) (Figures 4C–E). The gene discussed is MGMT; the disease is glioblastoma.